Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. Corius is the largest network of dermatology and phlebology practices in Germany and Switzerland.
By acquiring Mauritskliniek, Corius geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of Corius.
Mauritskliniek intends to join Corius in the third quarter of 2022, after potential approval of the Nederlandse Zorgautoriteit (NZa).
About Corius
Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. Corius offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. Corius has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de
About Mauritskliniek
Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.6/10 points, according zorgkaartnederland.nl. www.maurtiskliniek.nl
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
Emixa acquires Nextage Group to further strengthen its presence and focus on Digital Thread leadership in the Nordics
Our portfolio company Emixa, a leading European digital transformation consultancy and trusted partner for Siemens, SAP, Mendix and integration technologies, today announced the acquisition of Nextage Group, one of the most respected Siemens Digital Industries Software partners in the Nordic region.
Semalytix Secures €5.7 Million to Scale its Agentic AI Platform
Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its €5.7 million growth round.
HMCC Completes Add-On Investment in CareAbout
Our portfolio company HMCC proudly announces the successful completion of an add-on investment in CareAbout. This step brings together two strong organizations, joining forces to further support healthcare providers in ensuring continuity of care.
Abilia acquires portfolio company LivAssured
Abilia, a subsidiary of MedCap AB (publ) and part of Business Area Assistive Tech, has signed an agreement to acquire Holland Capital’s portfolio company LivAssured B.V.
Supply Chain Group and More Optimal Merge to Deliver Stronger End-to-End Supply Chain Solutions
Our portfolio company Supply Chain Group (consisting of Chainresult and Supply Chain Company) announced their merger with software company More Optimal
Actuals secures €3 million in Series A funding round led by Holland Capital
Actuals, a Dutch fintech that helps finance teams process millions of transactions without errors, has raised €3 million in a funding round led by investment firm Holland Capital.
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01





